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Abstract:  Multi-modal nanoparticles incorporating fluorophores are 
increasingly being used for medical applications. The number of 
fluorophores incorporated into the nanoparticles during synthesis is 
stochastic, leaving some nanoparticles devoid of fluorophores. Determining 
the number, the brightness and the photostability of the fluorophores 
incorporated, and the percentage of labeled nanoparticles (labeling 
efficiency) remains challenging. We have determined the aforementioned 
quantities for two synthesized multi-modal nanoparticles by exploiting the 
photobleaching of fluorophores at the single-molecule level using a total 
internal reflection fluorescence microscope. Labeling efficiency was 
determined by fitting the distribution of incorporated fluorophores with a 
statistical model and verified by independent experiments. 
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1. Introduction 
Multi-modal nanoparticles have been the subject of intense research in recent years for 
potential biomedical applications and have been approved by the US Food and Drug 
Administration (FDA) for use in humans [1–4]. Fluorophores are often incorporated in multi-
modal nanoparticles to facilitate fluorescent imaging. The number of fluorophores 
incorporated into nanoparticles during synthesis is statistically distributed. The statistics of 
fluorophore incorporation and hence the distribution of the number of incorporated 
fluorophores are impossible to obtain from ensemble assays. It is also challenging to 
characterize the incorporated fluorophores due to the inaccuracies in determining their 
number, brightness and photostability from ensemble assays. Typically, fluorophore content is 
analyzed by quantum yield (QY) analysis, which compares the relative absorbance and 
integrated fluorescence of the test sample to a well characterized standard sample. This 
technique relies on the assumption that  the solvents of the two samples and the samples 
themselves behave similarly, which is not the case when the nanoparticle has a core structure 
with its own absorbance spectrum, refractive index, and light scattering properties, and the 
fluorophore properties are altered by incorporation. Accurate determination of the number of 
fluorophores can therefore be problematic even though the molar equivalence of fluorophore 
reacted with particles is well-defined [5]. Moreover, near infrared (NIR) fluorophores are 
frequently chosen for in vivo imaging because of minimal background and superior tissue 
penetration [6]. Choosing an appropriate NIR standard fluorophore as a comparison reference, 
however, is difficult because most have very low QY values that vary greatly in the literature. 
In this paper, we have overcome the limitations of ensemble assays to characterize 
fluorophores incorporated into multi-modal nanoparticles at the single-molecule level. We 
present a Single Particle Observation Technique (SPOT) using a total internal reflection 
fluorescence microscope to directly characterize the fluorophores incorporated in individual 
nanoparticles by exploiting photobleaching. Photobleaching of a single fluorophore is 
characterized by sudden decrease of fluorescence intensity. The number of photobleaching 
steps indicates the number of incorporated fluorophores. By measuring the discrete decreases  
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Fig. 1. Single Particle Observation Technique. (a) Dual-modal magnetic resonance/optical 
fluorescence silica-coated iron oxide nanoparticles (SCION) were dispersed in a sample 
chamber. (b) When incident light hits the boundary of two media at an angle greater than a 
critical angle, θc, total internal reflection occurs resulting in an evanescent field that excites 
fluorophores in a thin layer near the surface (~200nm). (c) Schematic of the TIRF microscope. 
The excitation laser (green) is refracted by the quartz prism and totally internally reflected at 
the quartz slide-sample interface. The fluorescence emission is collected by a microscope 
objective, filtered to remove the excitation light and imaged by an EMCCD camera. 
in fluorescence intensity as incorporated fluorophores bleach over time, SPOT permits a direct 
measure of the number of incorporated fluorophores and the fluorophore labeling efficiency 
for multi-component nanoparticles. We demonstrate the technique by measuring the 
distribution of incorporated fluorophores in dual-mode magnetic resonance/optical 
fluorescence silica-coated iron oxide nanoparticles. SPOT analysis indicated that clusters of 
fluorophores rather than individual fluorophores were incorporated in these particles. The 
technique provides a rapid, robust, and sensitive means of determining the fluorophore 
labeling distribution while also providing details  of encapsulated fluorophore properties, 
including brightness and photostability. Compared to conventional ensemble measurement 
techniques with inherent population averaging, SPOT (Fig. 1) is a high-throughput approach 
to characterize hundreds of individual nanoparticles simultaneously. Previously, single-
molecule strategies related to nanomaterials have included characterizing QDs [7–9] and 
detecting attached targeting agents [10,11] or determining the stoichiometry of biological 
complexes such as membrane-bound protein assemblies [12–14]. In SPOT, photobleaching of 
individual fluorophores leads to a quantized decrease in emission intensity. The number of 
fluorophores incorporated in a nanoparticle can be determined from the number of discrete 
photobleaching steps, the brightness from the magnitude of the steps, and the photobleaching 
time from the time to the bleaching step (Fig. 2a). Fluorescence detection of individual 
fluorophores requires low background and high sensitivity measurements. Background 
fluorescence is reduced by exciting with the evanescent field generated in total internal 
reflection fluorescence microscopy (TIRFM), which limits the excitation to a ~200 nm layer 
at the surface of the slide (Fig. 1b). 
2. Materials and methods 
2.1. Materials 
Two ~18 nm dual-reporting (magnetic resonance and optical imaging) nanoparticles were 
synthesized by encasing ~10 nm ultrasmall superparamagnetic iron oxide nanoparticles in a 
layer of silica containing one of two conjugated fluorophores as described in Bumb et al. [5] 
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SCION(Alexa555) particles contained Alexa555 (Invitrogen). 
2.2. Single-molecule measurements 
Single molecule measurements were performed using a home-built prism-type TIRF 
microscope based on an Olympus IX71 [15]. A flow cell was made with double-sided tape 
(SA-S-1L 0.12 mm Grace BioLabs Secure-Seal adhesive double sided tape) sandwiched 
between a coverslip (Gold Seal 22 mm x 40 mm No.1) and a quartz slide (SPI 25 mm x 76 
mm x 1 mm). Slides and coverslips were soaked in Piranha solution (70% sulfuric acid and 
30% hydrogen peroxide) overnight, sonicated in 30% detergent (Alconox) solution for 1 h, 
and sonicated for three cycles of 30 min each in 1M NaOH followed by ethanol and finally in 
acetone, using fresh solution in each cycle. After each cycle, slides and coverslips were rinsed 
with DI water. Proper cleaning is essential for high signal-to-noise ratio in single particle 
fluorescence and phase contrast images. Free fluorophore or labeled or unlabeled SCION (100 
pM) were immobilized in 5% agar inside the flow cell to facilitate long observation times and 
limit diffusion. A quartz prism (CVI PLBC-5.0-79.5-SS) was used to obtain TIR at the 
interface of the quartz slide and agar in the flow cell over an area of ~150 x 150 μm
2. Laser 
powers of 3-12 mW at 532 nm (CrystaLaser GCL-025-L-0.5%) for SCION(Alexa555) and 
635 nm (CrystaLaser RCL-025-640-S) for SCION(Cy5.5) were used to excite the particles. 
Fluorescence was collected with an Olympus water immersion 1.2 NA 60X objective 
(UPLSAPO60XWIR). Additional magnification of 1.6X in the Olympus IX71 was used to 
obtain total magnification of 96X. Excitation light was rejected using HQ550LP filter for 532 
nm excitation and HQ660LP filter for 635 nm excitation (Chroma). Filtered fluorescence was 
detected by an EMCCD camera (Andor DV897DCS-BV). Andor iQ 1.8 software was used to 
control the camera and record movies. Movies of thousands of particles were recorded with 
100 ms time resolution. The fluorescence intensity of each particle as a function time was 
extracted from recorded movies using custom written IDL programs. Statistical analysis was 
performed using IGOR, Origin and Microsoft Excel. 
2.3. Fluorescent lifetime measurements 
Lifetime measurements were performed with a PTI Easylife LS fluorescence lifetime system 
using 525 nm excitation. Deconvolution fitting to obtain the lifetimes was performed with the 
accompanying software. 
2.4. Confirmation of labeling efficiency 
To confirm the predicted labeling efficiency based on statistical analysis of the distribution of 
incorporated fluorophores, we used an Olympus IX81 microscope outfitted with a spinning 
disk confocal head (Yukogawa head CSU-X1) with a 100× oil immersion objective lens (N.A. 
1.40) and an EMCCD camera (QuantEM 512SC, 16 μm pixel size; Photometrics). A flow cell 
made with a thoroughly cleaned quartz coverslip and a glass slide was used. SCION(Cy5.5) 
particles in PBS buffer were flowed into the flow cell. For each field of view, images of 
SCION(Cy5.5) were captured first in confocal fluorescence mode (640 nm excitation, laser 
power 50 μW, 300 ms exposure), followed by capturing a phase contrast image of the same 
spot with a halogen lamp (1 s exposure). This order of imaging enabled the identification of 
the focal plane with the fluorescent particles while minimizing photobleaching. The optimum 
optical set up for the phase contrast channel was determined by trial and error. The particles 
were most clearly visualized when the polarizer and analyzer were removed from the light 
path with the DPO100 DIC prism in place. It should be noted that our images are phase 
contrast images, not differential interference contrast images. In this configuration, the field 
diaphragm was adjusted to a position at which the particles appeared as black dots on a lighter 
background. Contrast was increased by background subtraction with a background image for 
each  field  of  view  from  a  plane  10  μm  below  the  focal  plane.  The  phase  contrast  and 
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correspondence between the two images was determined using the ImageJ “Colocalization 
Threshold” plugin and the “Nucleus Counter” plugin. The number of spots with one-to-one 
correspondence provides the number of particles labeled with fluorophores. The average size 
of these labeled particles was noted and the same “Nucleus Counter” plugin was used on the 
phase contrast image where the parameters were set to capture particles with the same average 
diameter as the labeled particles. The labeling efficiency was calculated from the ratio of 
particles found in the fluorescent (labeled particles only) and phase contrast (both labeled and 
unlabeled particles) images. 
 
Fig. 2. Number of fluorophores incorporated in nanoparticles. (a) Fluorescence intensity as a 
function of time for a SCION(Alexa555) particle (red) and background (grey). Bleaching of 
individual fluorophores results in discrete decreases in intensity (black arrows). The number of 
bleaching events reveals the number of fluorophores in the nanoparticle. The bleaching times 
are indicated by dashed lines. (b) Distribution of the number of fluorophores for 
SCION(Cy5.5) (red circles). Fitting to a single fluorophore incorporation model (Eq. (1)), blue 
line, reduced χ
2 = 3.3) returned an average of 1.58 ± 0.04 fluorophores per particle. Fitting to a 
fluorophore-cluster  incorporation  model  (see  text,  red  line,  reduced  χ
2  = 1.6) returned an 
average of 0.78 ± 0.02 clusters per particle, with an average of 1.7 ± 0.1 fluorophores per 
cluster determined from the free fluorophore distribution (inset). (c) Distribution of the number 
of fluorophores in SCION(Alexa555) (red circles). Fitting to a single fluorophore incorporation 
model (Eq. (1)), blue line, reduced χ
2 = 7.5) returned an average of 0.49 ± 0.02 fluorophores 
per particle. Fitting to a fluorophore-cluster incorporation model (see text, red line, reduced χ
2 
= 3.4) returned an average of 0.25 ± 0.02 clusters per particle, with an average of 1.15 ± 0.02 
fluorophores per cluster determined from the free fluorophore distribution (inset). The 
uncertainties in the fit parameters were obtained by bootstrap analysis [24]. The free 
fluorophore cluster distributions were approximated by Poisson distributions (Eq. (1)), which 
were corrected to account for the fact that the clusters contain at least one fluorophore. 
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To demonstrate SPOT analysis, we synthesized two ~18 nm dual-reporting (magnetic 
resonance and optical imaging) silica coated iron oxide nanoparticles (SCION) containing 
Cy5.5 (SCION(Cy5.5)) or Alexa555 (SCION(Alexa555)) fluorophores. Previously, the size, 
surface charge, structure, and magnetic properties of these nanoparticles were characterized 
[5,16]. 
However, quantum yield analysis of the SCION particles was not feasible due to the lack 
of suitable reference fluorophores and confounding optical effects such as scattering and 
absorbance of the iron oxide core. With a home-built SPOT instrument the number and 
properties of fluorophores encapsulated in individual SCIONs were determined and compared 
to free fluorophore. Fluorescence from particles was well above background and 
photobleaching was clearly visible as quantized steps (Fig. 2a). SCION(Cy5.5) had a mean of 
2.07 fluorophores/particle (s.d. = 1.32, n = 1324) whereas SCION(Alexa555) contained 1.31 
fluorophores/particle (s.d. = 0.69, n = 2957). Note, these means correspond to the number of 
fluorophores per labeled particle, not the average number of fluorophores per particle over the 
entire sample. To understand the distribution of the number of fluorophores per nanoparticle 
(Figs. 2b,c), we considered a simple model in which incorporation of fluorophores in the 
nanoparticle during synthesis is a random, non-cooperative process. Under these assumptions, 
the number of fluorophores per particle will follow a Poisson distribution [17]: 
  ()
!
ne
Pn
n
λ λ
−
=   (1) 
where, P(n) is the probability of there being n fluorophores incorporated in the particle and λ 
is the average number of incorporated fluorophores. The distributions of incorporated 
fluorophores were reasonably well fit by Poisson distributions for both particles (Fig. 2b, c). 
However, control experiments that measured the bleaching of free fluorophores in solution 
revealed that the free fluorophores did not all bleach in a single step as expected. Rather, a 
distribution of bleaching steps was observed indicative of aggregation of free fluorophores in 
solution (Figs. 2b, c). Aggregation of fluorophores is a well-known phenomenon of significant 
practical importance [18,19]. The number distributions of free fluorophore aggregates were 
similar to those of the labeled particles suggesting that clusters of fluorophores, rather than 
individual fluorophores, were incorporated into the nanoparticles. In this scenario, the 
distribution of the number of incorporated fluorophores would be a Poisson distribution for 
the number of clusters incorporated and the number of fluorophores in each cluster would be 
given by the measured distribution for the free fluorophore. To account for the incorporation 
of clusters of fluorophores rather than individuals, we fit the nanoparticle bleaching step 
distributions with a Poisson distribution for the number of clusters (c) incorporated: 
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cluster
particle
e
Pc
c
λ λ
−
=   (2) 
and a second Poisson distribution to describe the number of fluorophores in each incorporated 
cluster, 
  ( ) , d = 1, 2, 3… 
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dye d
dye
cluster
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d
λ λ
−
=   (3) 
Since a closed form of this expression is not readily obtained, the fitting was done via 
simulations. First, the distribution of free fluorophore cluster sizes (Pcluster) was fit with a 
Poisson distribution, which was assumed to be the same for the clusters incorporated into the 
nanoparticles. The distribution of the number of fluorophores in the nanoparticles was then 
simulated by assuming a Poisson distribution of incorporated fluorophore clusters, the size of 
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a range of average clusters per particle (λcluster) and the chi squared deviation between the 
simulated and experimental distributions was computed. The λcluster value with minimal chi 
squared deviation was taken as the best fit for the average number of incorporated clusters. 
SCION(Cy5.5) and SCION(Alexa555) bleaching step distributions were well fit by this 
function, resulting in lower chi squared values than the single Poisson fits (Eq. (1), Figs. 2b,c). 
The average probabilities of fluorophore incorporation were somewhat lower for this fit than 
for the single Poisson fit. 
The labeling efficiency is the probability that a particle will contain one or more clusters: 
 
Labeling  Efficiency ( 1)
1 (0)
1
cluster
particle
particle
Pc
P
e
λ −
= ≥
= −
= −
  (4) 
For SCION(Alexa555) and SCION(Cy5.5), the labeling efficiency obtained from the 
double Poisson fits were 22 ± 2% and 54 ± 2%, respectively. To experimentally confirm the 
calculated labeling efficiency, we directly compared the number of particles observed in 
fluorescence and phase contrast images of SCION(Cy5.5) (Fig. 3). Both labeled and unlabeled 
particles were observed by phase contrast imaging, whereas only fluorescently labeled 
particles were observed by confocal fluorescence imaging. Using this method, 40 ± 5% of 
SCION(Cy5.5) particles (n = 382) were labeled with at least one fluorophore, which is in 
reasonable agreement with the labeling efficiency of 54 ± 2% determined from the double 
Poisson fit, and is far less than the 79 ± 2% labeling efficiency obtained from a single Poisson 
fit to the data (Fig. 2b). Thus, statistical analysis of SPOT data as presented above can be used 
as a tool to measure the fluorophore labeling efficiency. 
Using SPOT, we observed that encapsulating fluorophores in SCION increased their 
brightness. The distribution of intensity steps of free fluorophore (Fig. 4a) versus encapsulated 
fluorophore (Fig. 4b) reveals that fluorophores in SCION silica shells were brighter than free 
fluorophores. The weighted mean photo-intensities for encapsulated Alexa555 were 3612, 
2698, and 2199 respectively at excitation powers of 12, 6, and 3 mW. This corresponded to a  
 
 
Fig. 3. Experimental confirmation of particle labeling efficiency. (a) Spinning disk confocal 
fluorescence image gives the number of nanoparticles with fluorophores. (b) Phase contrast 
image of the same field of view gives the total number of nanoparticles with and without 
fluorophores. Every spot on the fluorescence image has a corresponding point in the phase 
contrast image (examples are encircled). 
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enhancement of brightness was noted by Burns et al. [20] who used fluorescence correlation 
spectroscopy to study silica particles containing Cy5. To further understand the origin of this 
brightness increase we measured the fluorescence lifetimes (Fig. 4c). The number of excited 
fluorophores, F, decay by 
 
0 ()
1
t
i
Ft Fe
k
τ
τ
−
=
=∑
  (5) 
where the fluorescence lifetime, τ, is the inverse of the sum of the rates of individual decay 
pathways,  ki. In the case of free Alexa555, a single fluorescence lifetime of 228 ps was 
measured, whereas encapsulated fluorophores decayed with a fluorescence lifetime of 228 ps, 
as well as through a second pathway with a lifetime of 1.5 ns (Fig. 4c). Decrease [21] and 
increase [22] in emission intensity from fluorophores incorporated in silica have been 
reported, but were associated with a decrease of the fluorescence lifetime. Therefore, the 
observation of increased brightness of incorporated fluorophores with the simultaneous   
 
 
Fig. 4. Photophysical properties of free and encapsulated Alexa555. (a) Distribution of 
fluorophore intensity drops for free fluorophore and (b) for SCION particles from individual 
intensity traces (Fig. 2a). (c) Fluorescence decays and fits for free fluorophore (black) and 
SCION(Alexa 555) particles (red). The fluorescence lifetimes were determined from the 
deconvolution fits. Free fluorophores had a single lifetime of 228 ± 2 ps, whereas encapsulated 
fluorophores had two lifetimes of 228 ± 2 ps and 1.5 ± 0.1 ns. (d) Distribution of fluorophore 
bleaching lifetimes obtained from individual intensity traces (Fig. 2a) of SCION(Alexa 555) 
particles (red circles) and free fluorophores (black circles) at 6 mW of laser power. The 
distributions were fit with single-exponential decays. The lifetime of encapsulated fluorophores 
was 89 ± 4 s (red line, reduced χ
2 = 2.3), whereas the lifetime of free Alexa555 was 23 ± 2 s 
(black  line,  reduced  χ
2  = 0.85). (e) Bleaching time as a function of laser power for 
SCION(Alexa 555) particles (red) and free fluorophores (black). 
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required to verify the origin of the second decay pathway. 
We further observed that encapsulating fluorophore improved photostability as evidenced 
by increased photobleaching times. The distributions of photobleaching times for Alexa555 at 
excitation powers of 3-12 mW were well fit by exponential curves (Fig. 4d), as expected for 
an uncorrelated Poisson process. The average photobleaching time of SCION(Alexa555) 
encapsulated fluorophores was greater than three-fold longer than the bleaching time of free 
Alexa fluorophore (Fig. 4e). It is possible that photo-oxidation is reduced by encasing 
fluorophore in silica as there is a decreased amount of free oxygen. When molecular oxygen 
quenches a fluorophore’s dark triplet excited state, highly reactive singlet oxygen is produced 
that can react with and bleach the fluorophore. Thus, reducing the oxygen concentration 
prolongs fluorophore photobleaching time [23]. Silica is porous; hence, a non-porous coating 
material may further enhance the photostability of the encapsulated fluorophore. 
4. Conclusion 
SPOT represents an important addition to the molecular imaging and nanomedicine tool kit, 
as a method to analyze the molecular optical properties of fluorophores embedded into multi-
modal nanoparticles. The work presented demonstrates how the brightness and the 
photobleaching of individual fluorophores in a nanoparticle as a function of  time were 
recorded and analyzed. We have determined the number, the brightness, and the photostability 
of the fluorophores. Moreover, we have presented a statistical analysis to fit the number 
distribution to determine the statistics of fluorophore incorporation and to determine the 
percentage of labeled nanoparticles. Estimated labeling efficiency was independently 
confirmed using a combination of phase contrast and confocal fluorescence imaging. We 
observed that fluorophores encapsulated in silica had both increased brightness and improved 
photostability, both of which enhance the imaging properties of the nanoparticles. Our method 
is accurate, high throughput, and utilizes exceedingly small quantities of sample. Accurate 
results can be achieved with less than a femtomole of particles. 
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